The application of beta-tricalcium phosphate in implant dentistry: a systematic evaluation of clinical studies

Publication date

2022-03-08T19:08:39Z

2022-03-08T19:08:39Z

2021-01-16

2022-03-08T19:08:39Z

Abstract

The demand for synthetic graft materials in implant dentistry is rising. This systematic review aims to evaluate the survival rate of dental implants placed simultaneously with bone regeneration procedures using the material -tricalcium phosphate, one of the most promising synthetic graft materials. The electronic search was conducted in PubMed, Scielo, and the Cochrane Central Register of Controlled Trials. There were five randomized clinical trials, one of which was a non-randomized controlled clinical trial and four of which were observational studies without a control group included. Implant survival rate and other clinical, radiographic, and histological parameters did not differ from those of implants placed simultaneously with another type of graft material, or placed in blood clots or natural alveolar ridges. Based on the available literature, - tricalcium phosphate seems to be a promising graft material in implant dentistry. Nevertheless, more randomized clinical trials, with long follow-up periods, preoperative and postoperative CBCT, and histological analysis, are necessary to assess its long-term behavior.

Document Type

Article


Published version

Language

English

Publisher

MDPI

Related items

Reproducció del document publicat a: https://doi.org/10.3390/ma15020655

Materials, 2021, vol. 15, num. 655, p. 1-11

https://doi.org/10.3390/ma15020655

Recommended citation

This citation was generated automatically.

Rights

cc-by (c) Roca Millan, Elisabet et al., 2021

https://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)